Brexanolone
Showing 1 - 21 of 21
Tinnitus Trial (Brexanolone)
Not yet recruiting
- Tinnitus
- Brexanolone
- (no location specified)
Dec 1, 2022
PTSD, Alcohol Use Disorder Trial in New Haven (Brexanolone)
Not yet recruiting
- PTSD
- Alcohol Use Disorder
- Brexanolone
-
New Haven, ConnecticutYale School of Medicine
Jan 12, 2023
Brexanolone-induced Antidepressant Effects in Postpartum
Recruiting
- Postpartum Depression
- Brexanolone
-
Chapel Hill, North CarolinaUniversity of North Carolina
Sep 13, 2022
Post-Traumatic Stress Disorder Trial (Brexanolone Injection [Zulresso])
Not yet recruiting
- Post-Traumatic Stress Disorder
- Brexanolone Injection [Zulresso]
- (no location specified)
Feb 14, 2022
Acute Respiratory Distress Syndrome, COVID-19 Trial in United States (Brexanolone, Placebo)
Terminated
- Acute Respiratory Distress Syndrome
- COVID-19
- Brexanolone
- Placebo
-
Fresno, California
- +8 more
Aug 17, 2022
Depression Trial (brexanolone, )
Recruiting
- Depression
- brexanolone
- placebo
-
Boston, MassachusettsBrigham and Women's Hospital
Nov 8, 2022
Postpartum Psychosis Trial in Chapel Hill (Brexanolone)
Recruiting
- Postpartum Psychosis
- Brexanolone
-
Chapel Hill, North CarolinaUNC Hospitals
Mar 28, 2022
Postpartum Depression Trial (Brexanolone)
Withdrawn
- Postpartum Depression
- Brexanolone
- (no location specified)
Aug 14, 2020
Postpartum Depression Trial in Adelaide (BRII-297, Placebo)
Not yet recruiting
- Postpartum Depression
- BRII-297
- Placebo
-
Adelaide, South Australia, AustraliaCMAX
May 3, 2023
Postpartum Depression Trial (ZULRESSO (brexanolone) injection)
Approved for marketing
- Postpartum Depression
- ZULRESSO (brexanolone) injection
- (no location specified)
Jun 26, 2019
Fragile X-associated Tremor/Ataxia Syndrome Trial in Sacramento (Allopregnanolone)
Completed
- Fragile X-associated Tremor/Ataxia Syndrome
-
Sacramento, CaliforniaUC Davis MIND Institute
Nov 13, 2018
Severe Postpartum Depression Trial in United States (SAGE-547, Placebo)
Super-Refractory Status Epilepticus Trial in Worldwide (SAGE-547, Placebo)
Completed
- Super-Refractory Status Epilepticus
- SAGE-547
- Placebo
-
Birmingham, Alabama
- +172 more
Jan 20, 2022
Postpartum Depression Trial in Chapel Hill (SAGE-547)
Completed
- Postpartum Depression
-
Chapel Hill, North CarolinaSage Investigational Site
Jan 20, 2022
Postpartum Depression Trial in United States (Placebo, SAGE-547 90 µg/kg/h)
Completed
- Postpartum Depression
- Placebo
- SAGE-547 90 μg/kg/h
-
Chandler, Arizona
- +31 more
Jan 20, 2022
Super-Refractory Status Epilepticus Trial (SAGE-547)
No longer available
- Super-Refractory Status Epilepticus
- (no location specified)
Nov 10, 2017